1 Gale RP, "Why is there so much therapy-related AML and MDS and so little therapy-related CML" 38 : 1162-1164, 2014
2 Waller CF, "Treatment-related chronic myelogenous leukemia" 78 : 341-354, 1999
3 Aguiar RC, "Therapy-related chronic myeloid leukemia: an epidemiological, clinical and pathogenetic appraisal" 29 : 17-26, 1998
4 Gheith S, "The clinical relevance of detection of BCR-ABL in an asymptomatic patient : a case report and review of the literature" 3 : 1054-, 2015
5 Aye Le L, "Preleukemic phase of chronic myelogenous leukemia: morphologic and immunohistochemical characterization of 7 cases" 21 : 53-58, 2016
6 유동원, "Hidden “Preleukemic Phase” of Chronic Myeloid Leukemia Presenting Without Leukocytosis in the Peripheral Blood Unrelated to Chemotherapy in a Patient Diagnosed With Diffuse Large B Cell Lymphoma" 대한진단검사의학회 37 (37): 443-445, 2017
7 Berman E, "Duration of the preclinical phase of chronic myelogenous leukemia : a case report" 78 : 2969-2972, 1991
8 Millett R, "Chronic myeloid leukemia as secondary malignancy following the treatment of Hodgkin lymphoma : a case series" 39 : 4333-4335, 2019
9 이하영, "Chronic myeloid leukemia as a secondary malignancy after diffuse large B-cell lymphoma" 대한내과학회 29 (29): 250-252, 2014
10 Bolaños-Meade J, "CML after treatment for lymphoid malignancy : therapy-related CML or coincidence" 71 : 139-, 2002